Skip to main content
. Author manuscript; available in PMC: 2006 Jan 20.
Published in final edited form as: J Am Geriatr Soc. 2005 Jan;53(1):34–39. doi: 10.1111/j.1532-5415.2005.53007.x

Table 1.

Sociodemographic and health-related characteristics associated with anxiety: Women’s Health and Aging Study I (N = 1,002).

Variable No anxiety (N = 812) Anxiety (N = 190) p value
Age (M, SD) 78.3 (8.0) 78.4 (8.4) .94
Race (% African American) 30.3% 22.6% .04
Marital status (% married) 20.8% 22.1% .70
Education (M, SD) 9.9 (4.7) 9.9 (6.9) .94
Vision (% with problem) 15.6% 22.1% .03
Hearing (% with problem) 20.1% 24.7% .16
Number of diseases (M, SD) 2.0 (1.4) 2.5 (1.4) .01
BMI (M, SD) 28.5 (6.8) 27.8 (6.8) .23
Summary performance score (M, SD) 6.1 (3.2) 5.4 (3.4) <.001
Depressive symptoms (% scoring ≥ 10) 23.6% 66.3% <.001
Benzodiazepine use (M, SD) 7.1% 15.8% <.001
Physical activity (% active) 14.9% 11.9% .19
Emotional support (% had enough in prior year) 74.9% 47.4% < .001
Number of domains of disability (M, SD) 2.98 (0.86) 3.36 (0.78) < .001
Psychotropic medication use 16.5% 27.9% < .001
*

Note: Psychotropic medications include barbituates, monamine oxidase inhibitors, selective serotonin reuptake inhibitors, serotonin and norepinephrine reuptake inhibitors, trazadone, and tricyclics, and were used on a routine or prn basis.